Pfizer invests $120M in four biotechnological innovation companies
These updates are republished press releases and communications from members of the Science|Business Network Pfizer invests $120M in four biotechnological innovation companies Pfizer Inc. today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfiz...
Source: sciencebusiness.net